📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Kymab

1.1 - Company Overview

Kymab Logo

Kymab

Headquarter: United Kingdom
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of fully human monoclonal antibody therapeutics focused on immune-mediated diseases and immuno-oncology, developed using proprietary, integrated IntelliSelect platforms. IntelliSelect Transgenic platforms contain a full diversity of human antibodies.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Kymab

InnoPharma Logo

InnoPharma

HQ: United States Website
  • Description: Provider of niche-generic, specialty pharmaceutical and bio-pharmaceutical product development, operating as a privately held pharmaceutical R&D company founded in 2005 and based in Piscataway, New Jersey.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full InnoPharma company profile →
Valeo Pharma Logo

Valeo Pharma

HQ: Canada Website
  • Description: Provider of specialty pharmaceutical products and healthcare solutions, focused on commercializing innovative prescription therapies that address the needs of patients with complicated or rare diseases, serving healthcare professionals and patients.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Valeo Pharma company profile →
Palatin Technologies Logo

Palatin Technologies

HQ: United States Website
  • Description: Provider of targeted receptor-specific peptide therapeutics, including Vyleesi (bremelanotide injection) for premenopausal women with HSDD, and a pipeline of melanocortin-based candidates: PL9643 (Phase 3) for dry eye disease; PL9654 for ocular diseases (IVT and topical); PL8177 (oral, Phase 2) for ulcerative colitis; bremelanotide + PDE5i (Phase 2) for sexual dysfunction; and a planned MCR4 agonist program for obesity.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Palatin Technologies company profile →
Bliss Biopharma Logo

Bliss Biopharma

HQ: China Website
  • Description: Provider of tumor-targeting and immunotherapy therapeutics, focused on antibody-drug conjugates (ADCs). Offers BB-1701, an anti-HER2 ADC in international multi-center trials for HER2-positive solid tumors, and a diverse ADC pipeline in preclinical and clinical stages. Operates in-house, GMP-compliant antibody and ADC manufacturing to support clinical development and early commercialization.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Bliss Biopharma company profile →
Procemsa Logo

Procemsa

HQ: Italy Website
  • Description: Provider of development, production and packaging services for food supplements, medical devices and cosmetics, supported by state-of-the-art production facilities and a Research and Development Center, offering regulatory support, clinical trial services and stability studies.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Procemsa company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Kymab

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Kymab

2.2 - Growth funds investing in similar companies to Kymab

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Kymab

4.2 - Public trading comparable groups for Kymab

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Kymab

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Kymab

What does Kymab do?

Kymab is a provider of fully human monoclonal antibody therapeutics focused on immune-mediated diseases and immuno-oncology, developed using proprietary, integrated IntelliSelect platforms. IntelliSelect Transgenic platforms contain a full diversity of human antibodies.

Who are Kymab's competitors?

Kymab's competitors and similar companies include InnoPharma, Valeo Pharma, Palatin Technologies, Bliss Biopharma, and Procemsa.

Where is Kymab headquartered?

Kymab is headquartered in United Kingdom.

How many employees does Kymab have?

Kymab has 1,000 employees 🔒.

When was Kymab founded?

Kymab was founded in 2010 🔒.

What sector and industry vertical is Kymab in?

Kymab is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Kymab

Who are the top strategic acquirers in Kymab's sector and industry

Top strategic M&A buyers and acquirers in Kymab's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Kymab?

Top strategic M&A buyers groups and sectors for Kymab include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Kymab's sector and industry vertical

Which are the top PE firms investing in Kymab's sector and industry vertical?

Top PE firms investing in Kymab's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Kymab's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Kymab's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Kymab's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Kymab include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Kymab's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Kymab?

The key public trading comparables and valuation benchmarks for Kymab include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Kymab for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Kymab with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Kymab's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Kymab with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Kymab's' sector and industry vertical?

Access recent funding rounds and capital raises in Kymab's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Kymab